Outcomes of Acute Invasive Fungal Rhinosinusitis Patients Treated with Retrobulbar Amphotericin B Injections versus Orbital Exenteration.
作者信息
Fischer Jakob L, Kosaraju Nikitha, Lucarelli Katherine M, Wells Christine R, Sears Connie M, Karmouta Reem, Shirriff Ashley S, Weng Maxwell, Suh Jeffrey D, Lee Jivianne T, Beswick Daniel M, Rootman Daniel B, Wang Marilene B
机构信息
Department of Otolaryngology - Head and Neck Surgery, University of California Los Angeles, Los Angeles, California, USA.
Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
出版信息
Int Forum Allergy Rhinol. 2025 Jul;15(7):744-747. doi: 10.1002/alr.23573. Epub 2025 Mar 21.
Abstract
摘要
相似文献
1
Outcomes of Acute Invasive Fungal Rhinosinusitis Patients Treated with Retrobulbar Amphotericin B Injections versus Orbital Exenteration.
Int Forum Allergy Rhinol. 2025 Jul;15(7):744-747. doi: 10.1002/alr.23573. Epub 2025 Mar 21.
2
Transcutaneous Retrobulbar Amphotericin B Injection for Invasive Fungal Sinusitis with Orbital Involvement: A Systematic Review.
Am J Rhinol Allergy. 2024 Sep;38(5):339-353. doi: 10.1177/19458924241254422. Epub 2024 May 21.
3
Efficacy and safety of retrobulbar amphotericin B injection in invasive fungal rhinosinusitis with orbital invasion patients.
Rhinology. 2021 Aug 1;59(4):387-392. doi: 10.4193/Rhin21.070.
4
Orbital preservation in the treatment of acute invasive fungal sinusitis.
Am J Otolaryngol. 2024 Nov-Dec;45(6):104466. doi: 10.1016/j.amjoto.2024.104466. Epub 2024 Aug 7.
5
Orbital compartment syndrome following retrobulbar injection of amphotericin B for invasive fungal disease.
Am J Ophthalmol Case Rep. 2016 Feb 10;1:8-10. doi: 10.1016/j.ajoc.2016.01.003. eCollection 2016 Apr.
6
Combination endoscopic surgical debridement and transcutaneous retrobulbar amphotericin B for acute rhino-orbital-cerebral aspergillosis.
Am J Ophthalmol Case Rep. 2023 Jul 20;32:101903. doi: 10.1016/j.ajoc.2023.101903. eCollection 2023 Dec.
7
Outcomes of a Modified Treatment Ladder Algorithm Using Retrobulbar Amphotericin B for Invasive Fungal Rhino-Orbital Sinusitis.
Am J Ophthalmol. 2022 May;237:299-309. doi: 10.1016/j.ajo.2021.05.025. Epub 2021 Jun 9.
8
Retrobulbar Injection of Amphotericin B in Patients With COVID-19 Associated Orbital Mucormycosis: A Systematic Review.
Ophthalmic Plast Reconstr Surg. 2022;38(5):425-432. doi: 10.1097/IOP.0000000000002256. Epub 2022 Aug 8.
9
Chronic invasive fungal sinusitis with orbital and olfactory cleft involvement secondary to indolent mucormycosis.
Am J Ophthalmol Case Rep. 2022 Feb 18;26:101448. doi: 10.1016/j.ajoc.2022.101448. eCollection 2022 Jun.
10
Orbit management sans exenteration with retrobulbar injection of amphotericin-B in Rhinoorbitocerebral mucormycosis: Impact on survival.
Eur J Ophthalmol. 2025 Jul 30:11206721251361276. doi: 10.1177/11206721251361276.
本文引用的文献
1
Transcutaneous Retrobulbar Amphotericin B Injection for Invasive Fungal Sinusitis with Orbital Involvement: A Systematic Review.
Am J Rhinol Allergy. 2024 Sep;38(5):339-353. doi: 10.1177/19458924241254422. Epub 2024 May 21.
2
Transcutaneous retrobulbar amphotericin B for rhino-orbital-cerebral mucormycosis: a multi-center retrospective comparative study.
Orbit. 2024 Feb;43(1):41-48. doi: 10.1080/01676830.2023.2186435. Epub 2023 Mar 7.
3
Outcomes of a Modified Treatment Ladder Algorithm Using Retrobulbar Amphotericin B for Invasive Fungal Rhino-Orbital Sinusitis.
Am J Ophthalmol. 2022 May;237:299-309. doi: 10.1016/j.ajo.2021.05.025. Epub 2021 Jun 9.
4
Invasive Fungal Sinusitis: Risk Factors for Visual Acuity Outcomes and Mortality.
Ophthalmic Plast Reconstr Surg. 2019 Nov/Dec;35(6):535-542. doi: 10.1097/IOP.0000000000001357.
5
Survival outcomes in acute invasive fungal sinusitis: a systematic review and quantitative synthesis of published evidence.
Laryngoscope. 2013 May;123(5):1112-8. doi: 10.1002/lary.23912. Epub 2013 Jan 8.
6
Indications for orbital exenteration in mucormycosis.
Ophthalmic Plast Reconstr Surg. 2006 Jul-Aug;22(4):286-91. doi: 10.1097/01.iop.0000225418.50441.ee.
Zotero 插件